CatalystFDA/Bio

FDA APPROVED MODERNA'S MRNA FLU VACCINE AFTER INITIALLY REFUSING TO REVIEW IT - QZ

FDA approval of Moderna's mRNA flu vaccine after initial refusal signals major regulatory catalyst.

What changed

FDA approval of Moderna's mRNA flu vaccine after initial refusal signals major regulatory catalyst.

Why it matters

FDA approval of Moderna's mRNA flu vaccine after initial refusal signals major regulatory catalyst. — impact context not separately stored; see What changed.

Sources